Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
N-[isoleucinyl]-N'-[adenosyl]-diaminosufone is a synthetic small molecule and an analogue of isoleucyl-adenylate, structurally classified as a 5'-deoxyribonucleoside. It consists of an adenosine moiety linked via a sulfonamide group to an L-isoleucine residue. This compound has been used primarily as a biochemical tool in structural biology to mimic reaction intermediates in studies of aminoacyl-tRNA synthetases, particularly isoleucyl-tRNA synthetase (IleRS). It acts as a stable analogue of the enzyme's natural intermediate, allowing detailed investigation into the mechanism and fidelity of protein synthesis by these enzymes. There are no known therapeutic indications or clinical uses for this compound; it is considered experimental and mainly utilized in research settings.[1][2][3][5]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on N-[isoleucinyl]-N'-[adenosyl]-diaminosufone.